SSBP1 mutations cause mtDNA depletion underlying a complex optic atrophy disorder.


Journal

The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877

Informations de publication

Date de publication:
02 01 2020
Historique:
received: 28 02 2019
accepted: 19 09 2019
pubmed: 25 9 2019
medline: 25 7 2020
entrez: 25 9 2019
Statut: ppublish

Résumé

Inherited optic neuropathies include complex phenotypes, mostly driven by mitochondrial dysfunction. We report an optic atrophy spectrum disorder, including retinal macular dystrophy and kidney insufficiency leading to transplantation, associated with mitochondrial DNA (mtDNA) depletion without accumulation of multiple deletions. By whole-exome sequencing, we identified mutations affecting the mitochondrial single-strand binding protein (SSBP1) in 4 families with dominant and 1 with recessive inheritance. We show that SSBP1 mutations in patient-derived fibroblasts variably affect the amount of SSBP1 protein and alter multimer formation, but not the binding to ssDNA. SSBP1 mutations impaired mtDNA, nucleoids, and 7S-DNA amounts as well as mtDNA replication, affecting replisome machinery. The variable mtDNA depletion in cells was reflected in severity of mitochondrial dysfunction, including respiratory efficiency, OXPHOS subunits, and complex amount and assembly. mtDNA depletion and cytochrome c oxidase-negative cells were found ex vivo in biopsies of affected tissues, such as kidney and skeletal muscle. Reduced efficiency of mtDNA replication was also reproduced in vitro, confirming the pathogenic mechanism. Furthermore, ssbp1 suppression in zebrafish induced signs of nephropathy and reduced optic nerve size, the latter phenotype complemented by WT mRNA but not by SSBP1 mutant transcripts. This previously unrecognized disease of mtDNA maintenance implicates SSBP1 mutations as a cause of human pathology.

Identifiants

pubmed: 31550240
pii: 128514
doi: 10.1172/JCI128514
pmc: PMC6934201
doi:
pii:

Substances chimiques

DNA, Mitochondrial 0
DNA-Binding Proteins 0
Mitochondrial Proteins 0
SSBP1 protein, human 0
DNA Polymerase gamma EC 2.7.7.7

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108-125

Subventions

Organisme : Intramural NIH HHS
ID : Z01 ES065078
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Nat Genet. 2006 May;38(5):570-5
pubmed: 16582910
Anal Biochem. 2007 Nov 1;370(1):127-9
pubmed: 17662684
PLoS Genet. 2015 Jul 06;11(7):e1005349
pubmed: 26147622
Gene. 1993 Apr 30;126(2):219-25
pubmed: 8482537
Brain. 2010 Mar;133(Pt 3):771-86
pubmed: 20157015
PLoS One. 2015 Apr 24;10(4):e0125700
pubmed: 25909963
AIDS. 2005 Oct 14;19(15):1627-33
pubmed: 16184032
Am J Hum Genet. 2015 Jul 2;97(1):186-93
pubmed: 26094573
Brain. 2008 Feb;131(Pt 2):352-67
pubmed: 18222991
Science. 1988 Dec 9;242(4884):1427-30
pubmed: 3201231
Nat Rev Neurol. 2013 Aug;9(8):429-44
pubmed: 23835535
Am J Pathol. 2008 Oct;173(4):1120-8
pubmed: 18787099
Ophthalmology. 2014 Jan;121(1):234-245
pubmed: 24148654
Am J Hum Genet. 2006 Sep;79(3):544-8
pubmed: 16909392
Mol Cell. 2013 Jan 10;49(1):121-32
pubmed: 23201127
Methods Mol Biol. 2016;1351:211-22
pubmed: 26530685
Genomics. 1995 Jan 20;25(2):559-64
pubmed: 7789991
Biochim Biophys Acta Mol Basis Dis. 2018 Oct;1864(10):3496-3514
pubmed: 30293569
Hum Mol Genet. 2017 Oct 1;26(R2):R139-R150
pubmed: 28977448
PLoS Genet. 2014 May 29;10(5):e1004372
pubmed: 24875647
Brain. 2008 Feb;131(Pt 2):338-51
pubmed: 18158317
J Biol Chem. 1999 May 21;274(21):14779-85
pubmed: 10329675
Proc Natl Acad Sci U S A. 2015 Sep 8;112(36):11288-93
pubmed: 26305956
J Inherit Metab Dis. 2017 Jul;40(4):587-599
pubmed: 28324239
Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13534-9
pubmed: 21808029
Annu Rev Genet. 2012;46:265-87
pubmed: 22934639
Brain. 2018 Jan 1;141(1):55-62
pubmed: 29182774
Br J Ophthalmol. 2012 Feb;96(2):213-7
pubmed: 21558291
Nature. 1989 May 25;339(6222):309-11
pubmed: 2725645
Acta Neuropathol. 2016 Dec;132(6):789-806
pubmed: 27696015
PLoS Genet. 2019 Jan 3;15(1):e1007781
pubmed: 30605451
Int J Biochem Cell Biol. 2010 May;42(5):725-35
pubmed: 20080206
PLoS One. 2016 Aug 04;11(8):e0160519
pubmed: 27490490
Nat Genet. 2015 Aug;47(8):926-32
pubmed: 26168012
EMBO J. 2004 Jun 16;23(12):2423-9
pubmed: 15167897
Hum Mol Genet. 2009 Jan 1;18(1):12-26
pubmed: 18818194
Nucleic Acids Res. 2016 Apr 7;44(6):2501-13
pubmed: 26926108
J Med Genet. 2004 Sep;41(9):e110
pubmed: 15342707
Nat Genet. 2000 Oct;26(2):211-5
pubmed: 11017080
Brain. 2017 Oct 1;140(10):2586-2596
pubmed: 28969390
Nat Genet. 2013 Feb;45(2):214-9
pubmed: 23313956
Sci Rep. 2017 Mar 09;7:43992
pubmed: 28276514
Ann Neurol. 2006 Feb;59(2):276-81
pubmed: 16437557
Brain. 2008 Feb;131(Pt 2):329-37
pubmed: 18065439
Brain. 2012 Jan;135(Pt 1):23-34
pubmed: 22189565
Nat Genet. 2000 Oct;26(2):207-10
pubmed: 11017079
Methods Cell Biol. 2016;134:391-429
pubmed: 27312500
Methods. 2002 Apr;26(4):292-7
pubmed: 12054919
Ann Neurol. 2015 Jul;78(1):21-38
pubmed: 25820230
Invest Ophthalmol Vis Sci. 2011 Sep 21;52(10):7298-308
pubmed: 21778272
Hum Mutat. 2015 Oct;36(10):928-30
pubmed: 26220891
Am J Physiol Renal Physiol. 2007 Nov;293(5):F1746-50
pubmed: 17699558
Hum Mol Genet. 2013 May 15;22(10):1983-93
pubmed: 23393161
Brain. 2014 Feb;137(Pt 2):335-53
pubmed: 24369379
Nucleic Acids Res. 2010 Oct;38(19):6466-76
pubmed: 20530535
Genome Res. 2017 Oct;27(10):1715-1729
pubmed: 28864458
Am J Hum Genet. 1991 Mar;48(3):492-501
pubmed: 1998336
PLoS Genet. 2014 Dec 04;10(12):e1004832
pubmed: 25474639
Nucleic Acids Res. 2015 Oct 30;43(19):9262-75
pubmed: 26253742
Sci Rep. 2016 Jan 29;6:20267
pubmed: 26822689

Auteurs

Valentina Del Dotto (V)

Unit of Neurology, Department of Biomedical and NeuroMotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.

Farid Ullah (F)

Center for Human Disease Modeling, Duke University, Durham, North Carolina, USA.
Human Molecular Genetics Laboratory, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad, Pakistan.
Pakistan Institute of Engineering and Applied Sciences (PIEAS), Faisalabad, Pakistan.

Ivano Di Meo (I)

Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico C. Besta, Milan, Italy.

Pamela Magini (P)

Medical Genetics Unit, Sant'Orsola-Malpighi University Hospital, Bologna, Italy.

Mirjana Gusic (M)

Institute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany.
Institute of Human Genetics, Technische Universität München, Munich, Germany.

Alessandra Maresca (A)

IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Bologna, Italy.

Leonardo Caporali (L)

IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Bologna, Italy.

Flavia Palombo (F)

IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Bologna, Italy.

Francesca Tagliavini (F)

IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Bologna, Italy.

Evan Harris Baugh (EH)

Institute for Genomic Medicine, Columbia University, New York, New York, USA.

Bertil Macao (B)

Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.

Zsolt Szilagyi (Z)

Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.

Camille Peron (C)

Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico C. Besta, Milan, Italy.

Margaret A Gustafson (MA)

Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA.

Kamal Khan (K)

Center for Human Disease Modeling, Duke University, Durham, North Carolina, USA.
Human Molecular Genetics Laboratory, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad, Pakistan.
Pakistan Institute of Engineering and Applied Sciences (PIEAS), Faisalabad, Pakistan.

Chiara La Morgia (C)

Unit of Neurology, Department of Biomedical and NeuroMotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.
IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Bologna, Italy.

Piero Barboni (P)

Department of Ophthalmology, Studio Oculistico d'Azeglio, Bologna, Italy.

Michele Carbonelli (M)

IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Bologna, Italy.

Maria Lucia Valentino (ML)

Unit of Neurology, Department of Biomedical and NeuroMotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.
IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Bologna, Italy.

Rocco Liguori (R)

Unit of Neurology, Department of Biomedical and NeuroMotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.
IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Bologna, Italy.

Vandana Shashi (V)

Division of Medical Genetics and.

Jennifer Sullivan (J)

Division of Medical Genetics and.

Shashi Nagaraj (S)

Division of Nephrology, Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA.

Mays El-Dairi (M)

Neuro-Ophthalmology Service and.

Alessandro Iannaccone (A)

Center for Retinal Degenerations and Ophthalmic Genetic Diseases and Visual Function Diagnostic Laboratory, Duke Eye Center, Duke University School of Medicine, Durham, North Carolina, USA.

Ioana Cutcutache (I)

Translational Medicine, UCB Pharma, Slough, United Kingdom.

Enrico Bertini (E)

Unit of Muscular and Neurodegenerative Diseases, Department of Neurosciences, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Rosalba Carrozzo (R)

Unit of Muscular and Neurodegenerative Diseases, Department of Neurosciences, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Francesco Emma (F)

Division of Nephrology, Department of Pediatric Subspecialties, Bambino Gesù Children's Hospital, Rome, Italy.

Francesca Diomedi-Camassei (F)

Pathology Unit, Department of Laboratories, Bambino Gesù Children's Hospital, Rome, Italy.

Claudia Zanna (C)

Department of Pharmacy and Biotechnology (FABIT), University of Bologna, Bologna, Italy.

Martin Armstrong (M)

Translational Medicine, UCB Pharma, Braine-l'Alleud, Belgium.

Matthew Page (M)

Translational Medicine, UCB Pharma, Slough, United Kingdom.

Nicholas Stong (N)

Institute for Genomic Medicine, Columbia University, New York, New York, USA.

Sylvia Boesch (S)

Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.

Robert Kopajtich (R)

Institute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany.
Institute of Human Genetics, Technische Universität München, Munich, Germany.

Saskia Wortmann (S)

Institute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany.
Institute of Human Genetics, Technische Universität München, Munich, Germany.
Department of Pediatrics, Salzburger Landeskliniken and Paracelsus Medical University Salzburg, Salzburg, Austria.

Wolfgang Sperl (W)

Department of Pediatrics, Salzburger Landeskliniken and Paracelsus Medical University Salzburg, Salzburg, Austria.

Erica E Davis (EE)

Center for Human Disease Modeling, Duke University, Durham, North Carolina, USA.

William C Copeland (WC)

Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA.

Marco Seri (M)

Medical Genetics Unit, Sant'Orsola-Malpighi University Hospital, Bologna, Italy.
Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

Maria Falkenberg (M)

Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.

Holger Prokisch (H)

Institute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany.
Institute of Human Genetics, Technische Universität München, Munich, Germany.

Nicholas Katsanis (N)

Center for Human Disease Modeling, Duke University, Durham, North Carolina, USA.
Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
Departments of Pediatrics and Cellular and Molecular Biology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Valeria Tiranti (V)

Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico C. Besta, Milan, Italy.

Tommaso Pippucci (T)

Medical Genetics Unit, Sant'Orsola-Malpighi University Hospital, Bologna, Italy.

Valerio Carelli (V)

Unit of Neurology, Department of Biomedical and NeuroMotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.
IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH